It has been hypothesized that, at least in some types of ALS, neurodegeneration could be the result of a higher susceptibility to oxidative stress and experiments designed to test it have pointed to the involvement of AMPK activation. The gene discussed is PRKAA2; the disease is amyotrophic lateral sclerosis.